Cancer drug developer Oncternal Therapeutics will become publicly traded, under terms of a reverse merger announced Thursday. The San Diego company said it has agreed to purchase the majority ownership of GTx, a publicly traded biotech in Memphis, Tenn. The merged company will also be named Oncternal..
We as a team help everyone to get into a single umbrella to promote their products and services and reach out to maximum consumers. We market your products/services digitally with our huge database who all are already into the biotechnology sector.
@2019 Geno Tech. All rights reserved.
Contact Us
Email: info@genotech.in, genotech.in@gmail.com
India –
+91-8451877778
022-31705084
BWing – Space Plaza, Airoli, Navi Mumbai, Maharashtra, 400708
2739H Mancheswar Industrial Estate, Bhubaneswar, Odisha, 751010
Europe –
+31-645234077
Livingstonelaan 249, Utrecht Netherlands Postal code – 3526HG
Supported by :-
